These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 8175482)

  • 1. BE-23372M, a novel protein tyrosine kinase inhibitor. III. Synthesis.
    Tanaka S; Okabe T; Nakajima S; Yoshida E; Morishima H
    J Antibiot (Tokyo); 1994 Mar; 47(3):297-300. PubMed ID: 8175482
    [TBL] [Abstract][Full Text] [Related]  

  • 2. BE-23372M, a novel protein tyrosine kinase inhibitor. II. Physico-chemical properties and structure elucidation.
    Tanaka S; Okabe T; Nakajima S; Yoshida E; Suda H
    J Antibiot (Tokyo); 1994 Mar; 47(3):294-6. PubMed ID: 8175481
    [TBL] [Abstract][Full Text] [Related]  

  • 3. BE-23372M, a novel and specific inhibitor for epidermal growth factor receptor kinase.
    Tanaka S; Okabe T; Chieda S; Endo K; Kanoh T; Okura A; Yoshida E
    Jpn J Cancer Res; 1994 Mar; 85(3):253-9. PubMed ID: 8188523
    [TBL] [Abstract][Full Text] [Related]  

  • 4. BE-23372M, a novel protein tyrosine kinase inhibitor. I. Producing organism, fermentation, isolation and biological activities.
    Okabe T; Yoshida E; Chieda S; Endo K; Kamiya S; Osada K; Tanaka S; Okura A; Suda H
    J Antibiot (Tokyo); 1994 Mar; 47(3):289-93. PubMed ID: 8175480
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel antiproliferative agents derived from lavendustin A.
    Nussbaumer P; Winiski AP; Cammisuli S; Hiestand P; Weckbecker G; Stütz A
    J Med Chem; 1994 Nov; 37(24):4079-84. PubMed ID: 7990108
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and optimization of substituted furo[2,3-d]-pyrimidin-4-amines and 7H-pyrrolo[2,3-d]pyrimidin-4-amines as ACK1 inhibitors.
    Jiao X; Kopecky DJ; Liu J; Liu J; Jaen JC; Cardozo MG; Sharma R; Walker N; Wesche H; Li S; Farrelly E; Xiao SH; Wang Z; Kayser F
    Bioorg Med Chem Lett; 2012 Oct; 22(19):6212-7. PubMed ID: 22929232
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Radical arylation of phenols, phenyl ethers, and furans.
    Wetzel A; Pratsch G; Kolb R; Heinrich MR
    Chemistry; 2010 Feb; 16(8):2547-56. PubMed ID: 20066707
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and in vitro evaluation of diverse heterocyclic diphenolic compounds as inhibitors of DYRK1A.
    Zhou Q; Reekie TA; Abbassi RH; Indurthi Venkata D; Font JS; Ryan RM; Munoz L; Kassiou M
    Bioorg Med Chem; 2018 Dec; 26(22):5852-5869. PubMed ID: 30401502
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exploring skeletal diversity via ring contraction of glycal-derived scaffolds.
    Yeager AR; Min GK; Porco JA; Schaus SE
    Org Lett; 2006 Oct; 8(22):5065-8. PubMed ID: 17048844
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of atrial wall stretch-induced cardiac hormone secretion by lavendustin A, a potent tyrosine kinase inhibitor.
    Taskinen P; Toth M; Vuolteenaho O; Magga J; Ruskoaho H
    Endocrinology; 1999 Sep; 140(9):4198-207. PubMed ID: 10465292
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design, synthesis, and biological evaluation of a series of lavendustin A analogues that inhibit EGFR and Syk tyrosine kinases, as well as tubulin polymerization.
    Mu F; Coffing SL; Riese DJ; Geahlen RL; Verdier-Pinard P; Hamel TE; Johnson J; Cushman M
    J Med Chem; 2001 Feb; 44(3):441-52. PubMed ID: 11462983
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Two-step hydrothermal conversion of Pubescens to obtain furans and phenol compounds separately.
    Luo J; Xu Y; Zhao L; Dong L; Tong D; Zhu L; Hu C
    Bioresour Technol; 2010 Nov; 101(22):8873-80. PubMed ID: 20637603
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and biological evaluation of a novel series of furans: ligands selective for estrogen receptor alpha.
    Mortensen DS; Rodriguez AL; Carlson KE; Sun J; Katzenellenbogen BS; Katzenellenbogen JA
    J Med Chem; 2001 Nov; 44(23):3838-48. PubMed ID: 11689070
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Total Synthesis and Structural Revision of Clavilactone D.
    Takao KI; Nemoto R; Mori K; Namba A; Yoshida K; Ogura A
    Chemistry; 2017 Mar; 23(16):3828-3831. PubMed ID: 28229482
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A concise synthesis of a novel antiangiogenic tyrosine kinase inhibitor.
    Payack JF; Vazquez E; Matty L; Kress MH; McNamara J
    J Org Chem; 2005 Jan; 70(1):175-8. PubMed ID: 15624920
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Non-amine based analogues of lavendustin A as protein-tyrosine kinase inhibitors.
    Smyth MS; Stefanova I; Hartmann F; Horak ID; Osherov N; Levitzki A; Burke TR
    J Med Chem; 1993 Oct; 36(20):3010-4. PubMed ID: 8105084
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A tyrphostin-derived inhibitor of protein tyrosine kinases: isolation and characterization.
    Ramdas L; Obeyesekere NU; McMurray JS; Gallick GE; Seifert WE; Budde RJ
    Arch Biochem Biophys; 1995 Nov; 323(2):237-42. PubMed ID: 7487083
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Depression of neuronal protein synthesis initiation by protein tyrosine kinase inhibitors.
    Hu BR; Yang YB; Wieloch T
    J Neurochem; 1993 Nov; 61(5):1789-94. PubMed ID: 8228995
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and protein-tyrosine kinase inhibitory activity of polyhydroxylated stilbene analogues of piceatannol.
    Thakkar K; Geahlen RL; Cushman M
    J Med Chem; 1993 Oct; 36(20):2950-5. PubMed ID: 8411012
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tyrphostins I: synthesis and biological activity of protein tyrosine kinase inhibitors.
    Gazit A; Yaish P; Gilon C; Levitzki A
    J Med Chem; 1989 Oct; 32(10):2344-52. PubMed ID: 2552117
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.